“invivodata was able to deliver us the real-time data that we needed to develop an unbiased view into our patients’ pain experiences. This kind of data cannot be collected with paper diaries.”
Dr. Michael Gendreau
Chief Medical Officer, Cypress Bioscience
invivodata Named as Finalist in Pittsburgh Technology Council Tech 50 Awards
- October 20, 2008
invivodata Named as Finalist in Pittsburgh Technology Council Tech 50 Awards
invivodata Recognized as a Life Sciences Leader for New Product and Service Innovations
PITTSBURGH — invivodata inc., the industry leader in electronic patient reported outcomes (ePRO) solutions and services for global clinical research, has been recognized by the Pittsburgh Technology Council in its 2008 “Tech 50” awards. This marks the third consecutive year that invivodata has been named a Life Sciences category finalist in the annual awards, which honor high-growth companies in southwestern Pennsylvania’s technology sector.
Each year the Pittsburgh Technology Council’s Tech 50 awards honor those technology companies that demonstrate the strongest advancement in product or sales success, financial strength, and job growth and retention. invivodata was recognized for its continuing innovations in simplifying the process of capturing valid patient-reported outcomes (PRO) clinical trial data, including a comprehensive web-based ePRO management system, a first-of-its kind ePRO-EDC integration module, and consultative services that help researchers effectively develop PRO strategies to support their clinical research objectives.
“We continue to be impressed with invivodata’s technological advances and leadership in the growing market for clinical research technologies,” said Audrey Russo, president and CEO, Pittsburgh Technology Council. “We applaud invivodata’s commitment to the field of life sciences and its contribution to growing and sustaining Pittsburgh’s technology industry.”
“We’re honored to once again receive the Tech 50 recognition and to be considered one of Pittsburgh’s leading life sciences companies,” said Doug Engfer, invivodata president and CEO. “Our achievements are the direct result of our dedicated employees, who have been key to our continued growth, year after year.”
About invivodata inc.
invivodata combines behavioral science, information technology, and clinical research expertise to capture high quality clinical trial data directly from patients. invivodata’s electronic Patient Reported Outcomes (ePRO) solutions, which are based on over 20 years of research, deliver reliable patient self-reported data by driving patient compliance with the protocol and eliminating recall biases that plague paper-based self-report data. invivodata’s solutions include comprehensive trial-support services that facilitate the collection of ePRO data, and web-based access to study data and operational reports that give researchers and sponsors visibility into study progress and improve trial efficiencies. invivodata’s solution has been used in more than 200 trials and is the industry-leading ePRO system in delivering primary efficacy data for FDA
drug approvals. invivodata inc. is a privately held company with global headquarters in Pittsburgh, Pa., USA; its European headquarters is in London, England; and its technology development center is in Scotts Valley, Calif., USA. For more information visit www.invivodata.com.
